FDA Adverse Event Injury Summary report: N

DEPUY CMW 1G 40G

MDR report key: 17877328 · Received October 5, 2023

Report

Report Number
1818910-2023-20299
Event Type
Injury
Date Received
October 5, 2023
Date of Event
September 26, 2023
Report Date
October 5, 2023
Manufacturer
DEPUY ORTHOPAEDICS INC US
Product Code
LOD
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

PRODUCT COMPLAINT # (B)(4). THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803 (AND/OR PART 4, AS APPLICABLE). THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY DEPUY SYNTHES, OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, DEPUY SYNTHES, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 0

PRODUCT COMPLAINT #(B)(4). INVESTIGATION SUMMARY: NO DEVICE ASSOCIATED WITH THIS REPORT WAS RECEIVED FOR EXAMINATION. ACCORDING TO THE INFORMATION RECEIVED, "THE COMPLAINT IS THAT THE CEMENT IS SETTING VERY QUICKLY, THIS HAS HAPPENED ON A COUPLE OF CASES OVER THE PAST FEW WEEKS." LOT: 4071995. MANUFACTURING DATE: 30 JAN 23. EXPIRY DATE: 31 DEC 25. QUANTITY: (B)(4). THERE WAS ONE NON-CONFORMANCE ASSOCIATED WITH 4071995. THE NON-CONFORMANCE WOULD NOT HAVE AN ADVERSE EFFECT ON THE PERFORMANCE OF THE CEMENT. FINAL MICRO AND STERILITY TESTS PASSED. PRODUCT MET ALL QUALITY CONTROL ACCEPTANCE CRITERIA. PRODUCT CHECKED: RETURNED SAMPLES. REQUIRED TESTING: TM-T150 CEMENT HANDLING. THE SAMPLES RETURNED WERE TESTED IN A TEMPERATURE AND HUMIDITY-CONTROLLED LABORATORY. LOT: 4071995 (DEPUY CMW 1G). DOUGH TIME: 1 MIN 03 SECS (SPEC: 2 MIN 00S MAX). MIX CHARACTERISTICS: THIN. SETTING TIME: 8 MIN 34 SECS (SPEC 7 MIN 00S TO 10 MIN 30 SEC). THE CEMENT MIXED AND BEHAVED AS EXPECTED FOR THE PRODUCT TYPE AND MET APPROPRIATE SPECIFICATIONS (MS-039 SMARTSET GMV GENTAMICIN BONE CEMENT). AS PART OF OUR COMPANY QUALITY SYSTEM PROCESS, ALL DEVICES ARE MANUFACTURED, INSPECTED, AND DISTRIBUTED TO APPROVED SPECIFICATIONS. ADDITIONAL COMPLAINT INFORMATION MONITORING FOR POTENTIAL SAFETY SIGNALS WILL BE CONDUCTED THROUGH COMPLAINT TRENDING AS PART OF THE POST-MARKET SURVEILLANCE. IF ADDITIONAL INFORMATION IS MADE AVAILABLE, THE INVESTIGATION WILL BE UPDATED AS APPLICABLE. DEVICE HISTORY LOT: A MANUFACTURING RECORD EVALUATION WAS PERFORMED FOR THE FINISHED DEVICE 3315040, LOT 4071995 , AND NO NON-CONFORMANCES/MANUFACTURING IRREGULARITIES RELATED TO THE MALFUNCTION WERE IDENTIFIED.

Description of Event or Problem · 0

THE COMPLAINT IS THAT THE CEMENT IS SETTING VERY QUICKLY, THIS HAS HAPPENED ON A COUPLE OF CASES OVER THE PAST FEW WEEKS. WE WERE PROVIDED WITH DETAILS OF THE EFFECTS OF A PRIMARY HIP CASE STATING THE CEMENT SET AFTER 4 MINUTES. THIS RESULTED IN THE SURGEON BEING UNABLE TO IMPLANT THE CEMENTED HIP STEM CORRECTLY AND AS A RESULT THEY HAD TO REVISE THE HIP. THIS ADDED AN ADDITIONAL 1.5 HOURS ONTO THE SURGERY TIME AND THE PATIENT HAD TO HAVE A GENERAL ANAESTHETIC THAT THEY WERE NOT EXPECTING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
315985 DEPUY CMW 1G 40G BONE CEMENT : BONE CEMENT LOD DEPUY ORTHOPAEDICS INC US 4071995

Patients

Seq Age Sex Outcome Treatment
1 Unknown Required Intervention SMARTSET GHV GENTAMICIN 40G| SMARTSET GHV GENTAMICIN 40G